Spravato is offered as part of their behavioral health services for individuals who have not experienced sufficient relief with conventional depression treatments. Patients interested in Spravato typically undergo an initial assessment with a mental health provider to determine if they are appropriate candidates. When prescribed, the treatment is delivered as a supervised in-office nasal spray session, with dosing schedules individualized based on clinical needs, often starting with twice-weekly sessions before transitioning to maintenance. Verve’s clinicians work closely with patients throughout the process to monitor response, manage side effects, and coordinate ongoing mental health care as part of a comprehensive treatment plan.